These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19542662)

  • 1. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
    Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
    J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
    Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization.
    Vlachaki MT; Teslow TN; Amosson C; Uy NW; Ahmad S
    Med Dosim; 2005; 30(2):69-75. PubMed ID: 15922172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
    Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison.
    Digesú C; Cilla S; De Gaetano A; Massaccesi M; Macchia G; Ippolito E; Deodato F; Panunzi S; Iapalucci C; Mattiucci GC; D'Angelo E; Padula GD; Valentini V; Cellini N; Piermattei A; Morganti AG
    Med Dosim; 2011; 36(3):231-9. PubMed ID: 20541394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study.
    Guerrero M; Li XA; Earl MA; Sarfaraz M; Kiggundu E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1513-22. PubMed ID: 15275739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
    Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
    Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal dose reduction with IMRT for prostate radiotherapy.
    Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case study of radiotherapy planning for a bilateral metal hip prosthesis prostate cancer patient.
    Su A; Reft C; Rash C; Price J; Jani AB
    Med Dosim; 2005; 30(3):169-75. PubMed ID: 16112469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
    Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
    Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.